China’s International Import Expo (CIIE) is lighting up Shanghai with over 4,000 exhibitors from 155 nations, regions and international organizations.
Among them is a delegation of nearly two dozen Cuban companies, spanning sectors from biotechnology to pharmaceuticals. This showcase highlights Cuba’s growing focus on research-driven health solutions, as firms present everything from cutting-edge vaccines to advanced diagnostic tools.
For these Cuban innovators, CIIE offers more than exhibition space. It’s a gateway to new partnerships, market insights and cross-border investment opportunities. By connecting with global distributors, biotech startups and regulatory specialists, these companies aim to accelerate the international rollout of their discoveries.
Industry analysts note that Cuba’s biotech sector has a track record of pushing scientific boundaries despite resource challenges. Now, with a global stage like CIIE, the island’s researchers are pitching their solutions for widespread adoption—from affordable therapeutics to novel biologics.
As the expo continues, Cuba’s presence underscores a broader trend: emerging-market innovators are stepping onto the world stage, driven by data, collaboration and a shared mission to transform healthcare. For the young global citizens, entrepreneurs and changemakers tuning in, this is biotech diplomacy in action—where science meets trade to shape a healthier future.
Reference(s):
Cuba displays latest biotechnology, pharmaceutical companies at CIIE
cgtn.com
